Securities Class Action

No Litigation found for Neuphoria Therapeutics Inc.

Material Events

Critical Governance & Disclosure

5

Board, Voting & Shareholder Rights

2

Capital Structure & Financial Risk

1

Disclosure & Communications

5

SEC Filings

8-K

Current report

2026-10-23

View 8-K Current report on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-09-18

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-09-18

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov
DEF 14A

Other definitive proxy statements

2026-09-18

View DEF 14A Other definitive proxy statements on SEC.gov
10-K

Annual report

2026-09-18

View 10-K Annual report on SEC.gov

Insider Transaction

No Insider Transactions found for Neuphoria Therapeutics Inc.